An interventional study of Intervention Group in Prediabetes, sponsored by Diabetes Foundation, India. Not yet recruiting at 1 site in India. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-08-13.
Sponsored by Diabetes Foundation, India · Not applicable, Interventional, and Prevention
This is a randomized, controlled, two-phase crossover study will be conducted in adults aged 18-60 years with prediabetes to compare the effects of a CSIR-developed high-protein, low-glycaemic index rice with conventional rice. Phase I will evaluate acute postprandial glucose, insulin, C-peptide, GLP-1, and hunger/satiety responses, while Phase II will assess 72-hour continuous glucose monitoring (CGM) outcomes, including mean glucose and glycaemic variability. Eligible participants will be randomly assigned to receive both rice types in a crossover manner, with each participant serving as their own control. Individuals with diabetes, major systemic illnesses, abnormal liver or renal function, pregnancy, or glucose-lowering medication use will be excluded.
918 studies on the registry are indexed under Prediabetic State; 232 are open to participants now.
This study's planned enrollment of 36 is below the median of 62 across 762 interventional studies indexed under Prediabetic State.
Browse Prediabetic State studies →Diabetes Foundation, India is the lead sponsor of 30 studies on the registry; 14 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Individuals with prediabetes, defined by oral glucose tolerance test (OGTT) as:
Exclusion Criteria:
CSIR-Developed High-Protein, Low-Glycaemic Index Rice
Dietary Supplement: Intervention Group
Conventional Rice
Dietary Supplement: Intervention Group
High-Protein, Low-Glycaemic Index Rice
Also known as: CSIR-Developed High-Protein, Low-Glycaemic Index Rice
Study Phase 1: Meal Tolerance Test
incremental area under the curve(mg/dL)
Time frame: 1 day
meal tolerance study
• Postprandial insulin response (pmol/L)
Time frame: 1 day
Plan to share: No
No publications or documents are linked to this record.
This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Diabetes Foundation, India